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 Background: The use of ultraviolet (UV)-B irradiation after alloantigen immunization is unknown because previous studies 
focused on UV-B irradiation before immunization. Here, we investigated immunosuppressive effects induced 
by UV-B irradiation after immunization, and examined the phenotype of induced regulatory T cells and the pos-
sible mechanism of induction.
 Material/Methods: B6 mice (H-2b) were intravenously immunized by splenocytes from CBF1 mice (H-2b/d). One week after alloan-
tigen immunization, B6 mice received high-dose UV-B irradiation (40 kJ/m2). Four weeks after UV-B irradiation, 
proliferation assays (n=4, in each), transplantations with skin or cardiac allografts (n=5, in each), cytokines in 
mixed lymphocyte culture (n=6, in each), and adoptive transfer of CD4+ T cells to naïve B6 mice (n=5, in each) 
were performed. Mice were divided into 4 groups: untreated control, immunized control, UV-irradiated control, 
and an immunized and UV-irradiated group. B6C3F1 mice (H-2b/k) were used as irrelevant alloantigen with im-
munization controls. Anti-IL-10 monoclonal antibody was used to block IL-10 before and after UV-B irradiation.
 Results: Immune responses against the immunizing antigen were markedly suppressed in immunized and UV-irradiated 
mice in an alloantigen-specific manner. Surprisingly, CD4+ T cells from immunized and UV-irradiated mice pro-
duced significantly larger amounts of IL-10, in an alloantigen-specific manner. Moreover, alloantigen-specific 
immunosuppression via CD4+ regulatory T cells was transferable to naïve B6 mice. IL-10 blocking clearly ab-
rogated alloantigen-specific immunosuppression, indicating that UV-B irradiation evoked T regulatory type 1 
cells.
 Conclusions: This study demonstrates for the first time that immunization and UV irradiation induces alloantigen-specific 
CD4+ T regulatory type 1 cells, and that IL-10 plays an important role for this induction.
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Ultraviolet (UV) light, especially the mid-wave range (UV-B, 
280–320 nm), is an important environmental factor that af-
fects human health [1–5]. Although primary carcinogene-
sis is the most common problem, UV irradiation impairs im-
mune responses to oncologic and infectious antigens [1,4,6]. 
Paradoxically, immunosuppressive effects induced by UV irra-
diation may have therapeutic potential for autoimmune dis-
eases or host-versus-graft rejection [1,3,4,7–12]. Thus, UV-B 
irradiation is associated with clinical benefits.
Immunosuppressants have revolutionized clinical transplantation, 
but also cause pan-immunosuppressive effects [13]. Regulatory T 
cells (Tregs) are important in immunity [14–17], and alloantigen-
specific immunosuppression is critical for organ transplantation 
[7,10,16,18–20]. To date, our group has focused on applications 
of UV irradiation [21–25]. To induce alloantigen-specific Tregs, 
high-dose UV-B irradiation accompanied by alloantigen immuni-
zation is required [5,7,10,11,26–29]. In the late 1980s, many stud-
ies reported that antigen-specific Tregs were induced by high-
dose UV-B irradiation before antigen immunization [7,10,11,26], 
because it was thought that UV irradiation-induced alternation/
modulation of antigen-presenting cell (APC) functions were re-
quired for antigen-specific Treg induction [1,7,10,26,29–32].
The focus of our research group is to assess the application of 
alloantigen-specific immunosuppression in murine transplan-
tation models. The immune effect of UV-B irradiation after al-
loantigen immunization has not been established. Here, we 
investigated the use of UV-B irradiation after alloantigen immu-
nization to induce alloantigen-specific immunosuppression, and 
investigated the mechanism and phenotype of induced Tregs.
Material and Methods
Animals
UV-irradiated mice are a useful model to investigate antigen-
specific immunosuppression [7,10]. C57BL/6 (B6, H-2b), (BALB/
c×C57BL/6)F1 (CBF1, H-2
b/d), and (C57BL/6×C3H/HeN)F1 (B6C3F1, 
H-2b/k) mice were obtained from Japan SLC (Hamamatsu, Japan). 
These mice were maintained in a specific pathogen-free facili-
ty for laboratory animals at Mie University Graduate School of 
Medicine in accordance with institutional guidelines for animal 
welfare. To unify age and sex, 6-week-old female mice were 
used at the time of the first experimental procedure.
Study design and ethical approval
Study design is summarized in Figure 1. Although graft-ver-
sus-host disease is intractable in the field of bone marrow 
transplantation, host-versus-graft reaction and systemic im-
munoresponse are important for organ transplantation. Here, 
we mainly focused on organ transplantation to reduce post-
transplant rejection. Therefore, we set a semi-allogeneic com-
bination (not a full-allogeneic combination) in the model with 
delayed-type hypersensitivity (DTH). All experimental proce-
dures, including animal care, were approved by the Ethics 
Review Committee for Animal Experimentation of Mie University 
Graduate School of Medicine (No. 3106), based on the Ethics 
Guidelines of the Declaration of Helsinki.
Immunization with alloantigen
Spleens were removed from naïve CBF1 mice (H-2b/d). 
Splenocytes were freshly isolated, and resuspended in phos-
phate-buffered saline (PBS). A total of 2×107 cells/0.5 ml of 
single-cell splenocytes were intravenously injected into indi-
vidual age- and sex-matched naïve B6 mice (H-2b) via the lat-
eral tail vein.
Immunization with dendritic cells
Bone marrow-derived mature dendritic cells (DC) were obtained 
from naïve CBF1 mice (H-2b/d). Both thighbones were flushed 
with Hanks’ solution to obtain bone marrow cells. Red blood 
cells and T cells were depleted by sorting system (Dynal mag-
netic beads, Invitrogen, Life Technologies, Carlsbad, CA, USA). 
Culture medium comprised complete Roswell Park Memorial 
Institute (RPMI) medium (RPMI 1640, Nissui Pharmaceutical 
Co., Taito, Tokyo, Japan) supplemented with 10% fetal calf 
serum (FCS) (JRH Biosciences, Lenexa, KS, USA) and 0.5 mM 
2-mercaptoethanol (2-ME). Sterile flat-bottomed 6-well plates 
(Nunclon™ DSurface, Sigma-Aldrich, St. Louis, MO, USA) were 
used for cell culture. A total of 6×106 cells/3 ml/well were cul-
tured at 37°C. Granulocyte-macrophage colony-stimulating 
factor (GM-CSF) (500 U/0.5 ml) was added. Medium change 
and GM-CSF addition were performed on days 1−3, 5, and 7. 
Mature DC were obtained at day 8 by cell sorting (AutoMACS 
program; Miltenyi Biotec Inc., Auburn, CA, USA). Expression 
of MHC class II and CD11c were analyzed by flow cytometry, 
and the purity of DC was maintained at >90%. Age- and sex-
matched naïve B6 mice (H-2b) were immunized by intravenous 
injection of mature DC (2×106 cells/0.5 ml/mouse).
UV-B irradiation after alloantigen immunization
One week after alloantigen immunization, immunized B6 mice 
received UV-B irradiation. The UV source was a bank of 3 unfil-
tered UV lamps (UVP Inc., Upland, CA, USA) with an emission 
spectrum in the UV-B range (280–320 nm). The mean UV-B 
irradiation was 2372 mJ/cm2/h. A 10-cm2 area of the ventral 
skin was carefully shaved without injury to the abdominal 
wall. To prevent unevenness of UV-B irradiation, the feet of 
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anesthetized mice were fixed to a metallic halftone plate by 
silk threads. Thus, the shaved abdominal wall was sufficient-
ly extended and exposed equally to the UV lamps. The backs 
of mice, which were required for graft beds, were protected 
from UV irradiation.
Cell preparation of stimulator cells
To prevent cytokine release from stimulator T cells and prolif-
eration of the stimulator T cells themselves, X-irradiated and 
T cell-depleted single splenocytes from naïve CBF1 (H-2b/d) and 
B6C3F1 (H-2b/k) mice were prepared. To deplete T cells, single 
splenocytes were incubated with anti-Thy1.2 magnetic beads 
(Anti-Mouse CD90.2 [Thy-1.2] Particles-DM; BD Biosciences, 
Franklin Lakes, NJ, USA), and the procedures for T cell deple-
tion were performed using a sorting system (BD IMag system; 
BD Biosciences). T cell-depleted single splenocyte suspensions 
were X-irradiated at a dose of 28 Gy.
Mixed lymphocyte reactions
One-way allogeneic mixed lymphocyte reactions (MLR) were 
performed as proliferation assays in sterile flat-bottomed 96-
well plates for 96 h at 37°C. All cultures were set up in triplicate. 
Culture medium comprised complete RPMI medium supplement-
ed with 10% FCS, 0.5 mM 2-ME, and streptomycin. Unfractionated 
single splenocytes from B6 mice (5×105 cells) were cultured with 
either CBF1 or B6C3F1 stimulator cells (5×105 cells) in a total vol-
ume of 250 µl of culture medium in 96-well plates for 96 h at 
37°C. The cultures were pulsed with 1 μCi/well of [3H]-thymidine 
for the last 12 h of a 96-h culture and harvested onto glass fi-
ber filters. Proliferation was measured by [3H]-thymidine incor-
poration using liquid scintillation counting (counts per minute).
Skin transplantation
A whole-layer graft of tail skin was transplanted onto graft 
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Figure 1.  Study design. (A) Naïve B6 mice (H-2b) 
were intravenously immunized with 
splenocytes from naïve CBF1 mice 
(H-2b/d) (2×107 cells/0.5 ml/mouse). 
Immunized B6 mice received UV-B 
irradiation at a dose of 40 kJ/m2. At 
4 weeks after UV irradiation, harvest 
of splenic CD4+T cells and allograft 
transplantations were performed. (B) 
Splenic CD4+T cells were purified from 
immunized and UV-irradiated mice at 
4 weeks after UV irradiation. These 
CD4+T cells were transferred into 
age- and sex-matched naïve B6 mice. 
Transferred mice received allografts 
immediately.
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magnification). Skin grafts were harvested from age- and 
sex-matched donor mice. All grafts were unified to an area of 
10×5 mm to allow the quantitative uniformity of alloantigens. 
Under anesthesia, a syngeneic graft was transplanted onto the 
left- side back, while an allogeneic graft was grafted onto the 
right-side back. Transplanted grafts were wrapped in a ster-
ile bandage with an antibiotic ointment. Transplanted recipi-
ent mice were placed in separate cages to avoid scratching of 
transplanted grafts by cage mates. They were fed with a sup-
ply of Ringer’s lactate solution. Transplanted grafts were mon-
itored every day after bandage removal at day 7. Graft rejec-
tion was defined as >90% necrosis of graft epithelium [25,33].
Heart transplantation
As the second model, to confirm immunosuppressive effects in 
vivo, heterotopic heart transplantation was employed. Cardiac 
grafts were harvested from age- and sex-matched donor mice. 
Cardiac grafts were ectopically transplanted to recipient mice. 
Surgical procedures, including ultra-microsurgery, were de-
scribed previously [34]. Ultra-microsurgical procedures were 
performed under ×20 magnification (Surgical Scope M680, 
Type 10445496; Leica Microsystems Inc., Bannockburn, IL, 
USA). Transplanted mice were placed in separate cages, and fed 
with a supply of Ringer’s lactate solution. Graft rejection was 
defined as no palpable pulsation of heterotopic graft [28,35].
Cell preparation of splenic CD4+T cells
To prepare CD4+T cells, spleens were harvested from B6 mice. 
Single-cell suspensions of whole splenocytes (1×107 cells) 
were incubated with CD4 microbeads (CD4 [L3T4] MicroBeads; 
Miltenyi Biotec, Inc.) and positively selected over separation 
columns (AutoMACS program; Miltenyi Biotec, Inc.). To achieve 
a high purity of CD4+T cells, splenocytes were filtrated through 
the separation columns twice, although the total amount of 
sorted CD4+T cells was decreased. Purities of sorted CD4+T cells 
routinely contained >95% CD4+T cells (Figure 2).
Mixed lymphocyte cultures (MLC)
Culture medium comprised complete RPMI medium sup-
plemented with 10% FCS and 0.5 mM 2ME. Stimulator cells 
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Figure 2.  Purities of sorted CD4+T cells. Sorted splenic CD4+T cells routinely contained >95% of CD4+T cells (red).
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medium. Responder CD4+T cells were purified from B6 mice. 
Enriched splenic CD4+T cell suspensions from B6 mice (1×106 
cells/250 µl/well) were co-cultured with stimulator cells from 
naïve CBF1 or B6C3F1 mice (1×106 cells/250 µl/well) in ster-
ile 96-well flat-bottomed plates at 37°C. Supernatants were 
harvested after 24 h for analysis of productions of inter-
leukin (IL)-2, IL-6, and IL-8, and after 72 h for analysis of 
interferon (IFN)-g, IL-4, IL-5, IL-10, IL-13, and transforming 
growth factor (TGF)-b production. To stimulate responder T 
cells, 1 µg/mL/well of anti-CD3 monoclonal antibody (mAb) 
(145-2C11) was added, and supernatant was harvested after 
72 h for analysis of IL-10 production. The cultures were pulsed 
with 1 μCi/well of 3H-thymidine for the last 12 h, and incorpo-
ration of 3H-thymidinewas measured.
Enzyme-linked immunosorbent assay for cytokines
Concentrations of IFN-g, IL-2, IL-4, and IL-5 in supernatants from 
MLC were determined by enzyme-linked immunosorbent as-
say (ELISA) using a pair of anti-cytokine-specific mAb, as de-
scribed previously [36]. The lower detection limits for IFN-g, 
IL-2, IL-4, and IL-5 were 100, 30, 10, and 10 pg/ml, respec-
tively. Concentration of IL-6 was quantified using an ELISA kit 
(Mouse IL-6 ELISA; BD Biosciences). The lower limit of detec-
tion for IL-6 was 15.6 pg/ml. Concentration of IL-8 was quan-
tified using an ELISA kit (IL-8 ELISA kit; Funakoshi Frontiers 
in Life Science, Tokyo, Japan). The lower limit of detection 
for IL-8 was 10 pg/ml. Concentrations of IL-10 and IL-13 in 
the supernatants of MLC were quantified using ELISA kits 
(Quantikine Mouse IL-10 Immunoassay and Quantikine Mouse 
IL-13 Immunoassay; R&D Systems Inc., Minneapolis, MN, USA) 
according to the manufacturer’s recommendations. The lower 
detection limits for IL-10 and IL-13 were 31.3 and 125 pg/ml, 
respectively. Concentrations of TGF-b were measured by ELISA 
kit (Mouse TGF-beta1 Platinum ELISA; eBioscience, Inc., San 
Diego, CA, USA). Samples were diluted 10-fold, and the lower 
detection limit for TGF-b was 120 pg/ml.
Serum levels of IL-10 peaked at 4 days after high-dose UV-B 
irradiation [27]. Peripheral blood samples were obtained at 
days 1−5 and 7 after UV irradiation. Serum concentrations of 
IL-10 were measured by ELISA.
Adoptive transfer of CD4+T cells
Single splenocytes were isolated from B6 mice treated with 
immunization and UV irradiation. Four weeks after UV irradia-
tion, splenic CD4+T cells were purified and resuspended in PBS. 
CD4+T cells at concentrations of 5×105, 1×106, 3×106, 5×106, 
1×107, and 5×107 cells/100 µl/mouse were intravenously in-
jected into age- and sex-matched naïve B6 mice via the later-
al tail vein. PBS-transferred mice served as controls.
IL-10 blocking
To block IL-10, culture medium from a hybridoma-secreting an-
ti-IL-10 antibody (JES5-2A5, rat immunoglobulin G [IgG]) was 
used. The monoclonal antibody (mAb) was diluted in PBS, and 
a total of 250 µg/100 µl was intravenously injected into B6 
mice, on the day before (day –1) and after (day +1) UV irradi-
ation. In preliminary study, we confirmed the effect of this an-
ti-IL-10 antibody in comparisons with control rat IgG (Sigma 
Chemical, St. Louis, MO, USA).
Statistical analysis
Results are presented as mean ± standard deviation. The t-
test was used for the comparison of unpaired continuous vari-
ables between groups. Survival curves were constructed by the 
Kaplan-Meier method, and the log-rank test was used for be-
tween-group comparisons. Statistical calculations were per-
formed by statistical software (Stat View-J 5.0, SAS Institute 
Inc., Cary, NC, USA). A p value <0.05 was considered statistical-
ly significant, and p ≥0.05 was defined as not significant (NS).
Results
Dose of UV-B irradiation
First, immunosuppressive effects were evaluated at various dos-
es of UV-B. Mice were immunized and received various doses of 
UV-B at 1 week after immunization. At 1 week after UV irradiation, 
splenocytes were obtained from immunized and UV-irradiated 
mice. Proliferation assay by MLR was performed with stimulator 
cells presenting either the immunizing or irrelevant alloantigen. 
Proliferation assays by MLR were repeated 4 times (Figure 3A).
Stimulation with immunizing antigen and UV-B irradiation at 10 
kJ/m2 (p=0.0331), 20 kJ/m2 (p<0.0001), 30 kJ/m2 (p<0.0001), 40 
kJ/m2 (p<0.0001), 50 kJ/m2 (p<0.0001), and 60 kJ/m2 (p=0.0002) 
showed significant changes in 3H-TdR incorporation compared 
with control mice receiving 0 kJ/m2 UV-B irradiation. Stimulation 
with an irrelevant antigen and UV-B irradiation at 10 kJ/m2 
(p=0.0109), 20 kJ/m2 (p=0.0009), 30 kJ/m2 (p=0.0008), 40 kJ/
m2 (p=0.0004), 50 kJ/m2 (p=0.0032), and 60 kJ/m2 (p=0.0003) 
showed significant changes in 3H-TdR incorporation compared 
with control mice receiving 0 kJ/m2 UV-B irradiation.
Responses to the immunizing antigen were suppressed ac-
cording to UV-B dose, although immunosuppressive effects 
appeared to plateau at >40 kJ/m2. However, responses to the 
irrelevant antigen were also suppressed at 1 week after UV 
irradiation. In addition, a UV-B dose of 60 kJ/m2 was fatal for 
mice. Hence, a dose of 40 kJ/m2 of UV-B was used for all oth-
er experiments in this study (Figure 1)
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Temporal immunosuppressive effects of UV-B irradiation 
for the irrelevant antigen
As described above, responses to an irrelevant antigen were 
also suppressed at 1 week after UV irradiation. The recover-
ies of responses to the irrelevant antigen were evaluated at 
various time points after UV irradiation. Immunized mice re-
ceived 40 kJ/m2 of UV-B at 1 week after immunization. At vari-
ous time points after UV irradiation, splenocytes were obtained 
from immunized and UV-irradiated mice and proliferation as-
says by MLR were performed with stimulator cells presenting 
either immunizing antigen or irrelevant alloantigen (Figure 3B). 
Proliferation assays by MLR were repeated 4 times each.
Stimulation with the immunizing antigen induced significant 
differences in 3H-TdR incorporation at 1 week (p<0.0001), 2 
weeks (p<0.0001), 3 weeks (p<0.0001), 4 weeks (p=0.0001), 5 
weeks (p=0.0006), and 6 weeks (p<0.0001) after UV irradiation 
compared with non-UV irradiated mice (week 0).
Stimulation with an irrelevant antigen induced significant dif-
ferences in 3H-TdR incorporation at 1 week (p=0.0004), 2 weeks 
(p=0.0001), and 3 weeks (p=0.0018) after UV irradiation com-
pared with non-UV irradiated mice (week 0). However, 3H-TdR 
incorporation at 4 weeks (p=0.0630), 5 weeks (p=0.0562), or 
6 weeks (p=0.3695) after UV irradiation was not significantly 
different from non-UV irradiated mice (week 0).
Responses to immunization with an irrelevant antigen disap-
peared at 4 weeks after UV irradiation, whereas all responses to 
the immunizing antigen were suppressed. Hence, a time point 
of 4 weeks after UV irradiation was used in this study (Figure 1)
L2 Immunosuppressive effect induced by UV irradiation alone
Transplantations with skin or cardiac allografts were performed 
at 1 week after UV irradiation. Mice were divided into 4 groups: 
(i) untreated control, (ii) immunized control (iii), UV-irradiated 
control, and (iv) immunized/UV-irradiated group. Skin or heart 
Stimulator cells of H-2b/d alloantigen (CBF1)
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Figure 3.  Proliferation assays at various doses 
of UV-B irradiation and at various 
time points after UV irradiation 
(A) Proliferation assays at various 
doses of UV-B irradiation. In each of 
stimulations with the immunizing 
or irrelevant antigen, 3H-TdR 
incorporations at 10−60 kJ/m2 were 
compared with non-UV irradiated mice 
(0 kJ/m2), respectively. (B) Proliferation 
assays at various time points after UV 
irradiation. In each of stimulation with 
the immunizing or irrelevant antigen, 
3H-TdR incorporations at 1−6 week(s) 
after UV irradiation were compared 
with non-UV irradiated mice (week 0), 
respectively. *, p<0.05.
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transplantations were performed in 5 mice per group. No re-
jections were observed following syngeneic grafts. Survival 
curves are shown in Figure 4.
In skin transplantation with allografts presenting the immu-
nizing antigen, there were significant differences in allograft 
survival in the UV-immunized control (p=0.0016) and immu-
nized/UV-irradiated group (p=0.0016) but not immunized 
controls (p=0.3711) compared with the untreated controls 
(Figure 4A). In skin transplantation with allografts present-
ing an irrelevant antigen, there were significant differenc-
es in allograft survival in UV-immunized control (p=0.0023) 
and immunized/UV-irradiated groups (p=0.0023) but not im-
munized controls (p=0.1763) compared with untreated con-
trols (Figure 4B).
In heart transplantation with allografts presenting the im-
munizing antigen, there were significant differences in al-
lograft survival in the UV-immunized control (p=0.0062) and 
immunized/UV-irradiated groups (p=0.0062) but not immu-
nized controls (p=0.7209) compared with untreated controls 
(Figure 4C). In heart transplantation with allografts present-
ing an irrelevant antigen, there were significant differences 
in allograft survival in the UV-immunized control (p=0.0051) 
and immunized/UV-irradiated groups (p=0.0051) but not im-
munized controls (p=0.8585) compared with untreated con-
trols (Figure 4D).
At 1 week after UV irradiation, UV-B irradiation alone showed 
immunosuppressive effects in transplantations with allografts 
regardless of which antigen was used for immunization.
Alloantigen-specific immunosuppressive effects induced by 
immunization and UV irradiation
Mice were divided into 4 groups: (i) untreated control, (ii) im-
munized control, (iii) UV-irradiated control, and (iv) immunized/
UV-irradiated group. Splenic responder cells at 4 weeks after 
UV irradiation were cultured with stimulator cells presenting 
either the immunizing or irrelevant alloantigens (Figure 5). 
Proliferation assays by MLR were repeated 4 times each.
Immunizing antigen stimulation of the immunized/UV-irradiated 
group (p=0.0006) but not the immunized control (p=0.2153) or 
UV-irradiated control group (p=0.2459) showed significant dif-
ferences in 3H-TdR incorporation compared with the untreat-
ed controls. However, there were no significant differences in 
3H-TdR incorporation between all groups and unstimulated 
controls when stimulated with an irrelevant antigen.
Responses to the immunizing antigen were markedly sup-
pressed in immunized and UV-irradiated mice, in an alloanti-
gen-specific manner.
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Figure 4.  Allograft survival at 1 week after UV irradiation. (A) Survival of skin allografts presenting the immunizing alloantigen. 
(B) Survival of skin allografts presenting an irrelevant alloantigen. (C) Survival of cardiac allografts presenting the immunizing 
alloantigen. (D) Survival of cardiac allografts presenting an irrelevant alloantigen.
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Alloantigen-specific prolongation of allograft survival 
induced by immunization and UV irradiation
Transplantations with skin or cardiac allografts were per-
formed at 4 weeks after UV irradiation. Mice were divided 
into 4 groups, as described above. Skin or heart transplan-
tations were respectively performed in 5 mice per group. No 
rejections were observed in syngeneic grafts. Survival curves 
are shown in Figure 6.
In skin transplantation with allografts presenting the immu-
nizing antigen, there were significant differences in allograft 
survival of the immunized/UV-irradiated group (p=0.0052) but 
not the immunized control (p=0.1763) and UV-immunized con-
trol groups (p=0.2034) when compared with untreated controls 
(Figure 6A). In skin transplantation with allografts presenting 
the irrelevant antigen, there was no significant difference in 
allograft survival of all groups when compared with the un-
treated controls (p=0.0568) (Figure 6B).
In heart transplantation with allografts presenting the immuniz-
ing antigen, there were significant differences in allograft surviv-
al of the UV-immunized control (p=0.0110) and immunized/UV-
irradiated groups (p=0.0046) but not of the immunized control 
(p=0.4642) when compared with the untreated controls (Figure 6C). 
In heart transplantation with allografts presenting the irrelevant 
antigen, there were significant differences in allograft surviv-
al of the UV-immunized control (p=0.0120) and immunized/UV-
irradiated group (p=0.0262) but not immunized controls (p=0.3093) 
when compared with the untreated controls (Figure 6D).
At 4 weeks after UV irradiation, although immunosuppres-
sive effects by UV-B irradiation alone were still observed in 
transplantation with cardiac allografts, an alloantigen-specific 
prolongation of skin allograft survival was confirmed in immu-
nized and UV-irradiated mice.
Immunization by DC
An interesting question arose from these experiments. Allografts 
were finally rejected, even though immunized and UV-irradiated 
mice showed an alloantigen-specific prolongation of allograft 
survival. Therefore, does immunization by mature DC cause 
stronger immunization and subsequent induction of greater 
alloantigen-specific immunosuppression in immunized and UV-
irradiated mice? Using the transplant model, our preliminary 
study demonstrated that alloantigen immunization by intra-
peritoneal injection failed to induce alloantigen-specific immu-
nosuppression or showed only weak immunosuppression (data 
not shown). Therefore, we used DC to provide a stronger im-
munization to induce greater immunosuppression.
Proliferation assays stimulated with the immunizing antigen 
and transplantation with skin or cardiac allografts presenting 
the same alloantigen were performed at 4 weeks after UV irra-
diation. Mice were divided into 5 groups: (i) untreated control, 
(ii) immunized control, (iii) immunized by DC (iv) immunized/
UV-irradiated control, and (v) immunized by DC/UV-irradiated 
group. Proliferation assays by MLR were repeated 4 times each. 
Five mice were used for skin or heart transplantations. No re-
jections were observed in syngeneic grafts.
Proliferation assays measuring 3H-TdR incorporation in un-
treated controls were examined first. There was no significant 
difference in 3H-TdR incorporation between immunized con-
trols and the immunized DC group (p=0.2484) and between 
the immunized/UV-irradiated control and immunized by DC/
UV-irradiated groups (p=0.7173).
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Figure 5.  Proliferation assays at 4 weeks after 
UV irradiation. *, p<0.05.
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Skin transplantation studies showed no significant difference 
in allograft survival between immunized controls and the im-
munized by DC group (p=0.0.8741) and between the immu-
nized/UV-irradiated control and immunized by DC/UV-irradiated 
groups (p=0.6693). In heart transplantation studies, there was 
no significant difference in allograft survivals between the im-
munized group and immunized by DC group (p=0.0.8741) and 
between the immunized/UV-irradiated group and immunized 
by DC/UV-irradiated group (p=0.5003).
Although we hypothesized mature DC may have a difference 
in allograft survival, this was not observed experimentally.
Characterization of Treg induced by immunization after UV 
irradiation
To characterize whether Treg mediated alloantigen-specific 
immunosuppression in immunized and UV-irradiated mice, 
we investigated cytokine production profiles of CD4+T cells 
by alloantigen stimulation. To prepare CD4+T cells as respond-
ers, spleens were harvested from 4 B6 mice (H-2b) and divid-
ed into 4 groups: (i) untreated control, (ii) immunized control, 
(iii) UV-irradiated control, and (iv) immunized/UV-irradiated 
group. CD4+T cells were isolated at 4 weeks after UV irradia-
tion. Enriched CD4+T cells from each group were co-cultured 
with X-irradiated T cell-depleted splenocytes from CBF1 mice 
(H-2b/d) or B6C3F1 mice (H-2b/k). These MLCs were repeated 
6 times, and supernatants were harvested for ELISA assay 
(Figure 7).
Proliferation in the MLC plate was measured. There was no sig-
nificant difference in 3H-TdR incorporation between all groups 
and the untreated control when stimulated with the immuniz-
ing or irrelevant antigens (Figure 7A).
Stimulation with the immunizing alloantigen showed significant 
differences in IFN-g production in the immunized/UV-irradiated 
group (p=0.0010) but not the immunized controls (p=0.3261) 
or UV-irradiated controls (p=0.0772) compared with untreat-
ed controls. There was no significant difference in IFN-g pro-
duction between all groups and untreated controls when stim-
ulated with the irrelevant antigen (Figure 7B).
Stimulation with the immunizing alloantigen showed significant 
differences in IL-2 production in the immunized/UV-irradiated 
group (p=0.0004) but not the immunized controls (p=0.8274) 
or UV-irradiated controls (p=0.0924) compared with untreat-
ed controls. There was no significant difference in IL-2 produc-
tion between all groups and untreated controls when stimu-
lated with the irrelevant antigen (Figure 7C).
Concentrations of IL-4 and IL-8 were under the detection lim-
it when cells were stimulated with the immunizing or irrele-
vant alloantigen (Figure 7D, 7G).
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Figure 6.  Allograft survivals at 4 weeks after UV irradiation. (A) Survival of skin allografts presenting the immunizing alloantigen. 
(B) Survival of skin allografts presenting an irrelevant alloantigen. (C) Survival of cardiac allografts presenting the immunizing 
alloantigen. (D) Survival of cardiac allografts presenting an irrelevant alloantigen.
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Figure 7.  Cytokine profiles in MLC supernatants. (A) Proliferation of responder CD4+T cells. (B) IFN-g concentration. (C) IL-2 
concentration. (D) IL-4 concentration. (E) IL-5 concentration. (F) IL-6 concentration. (G) IL-8 concentration. (H) IL-10 
concentration. (I) IL-13 concentration. (J) TGF-b concentration. *, p<0.05; dotted line, the detection limit.
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There were no significant differences in the productions of 
IL-5, IL-6, and IL-13 between all groups when stimulated with 
the immunizing or irrelevant alloantigen (Figure 7E, 7F, 7I).
Stimulation with the immunizing alloantigen showed signif-
icant differences in IL-10 production in the immunized/UV-
irradiated group (p=0.0004) but not the immunized controls 
and UV-irradiated controls when compared with the untreat-
ed controls. There was no significant difference in IL-10 pro-
duction between all groups and untreated controls when stim-
ulated with the irrelevant antigen (Figure 7H).
There was no significant difference in TGF-b production be-
tween all groups when stimulated with the immunizing or ir-
relevant alloantigen (Figure 7J).
Data from the current study demonstrated that immunosup-
pression by immunization and UV-B irradiation did not depend 
on IL-4 or TGF-b, and suggested that the mechanism involved 
in immunosuppression was not a simple Th2 shift. CD4+T cells 
from immunized and UV-irradiated mice produced significantly 
greater amounts of IL-10 but smaller amounts of IL-2 and IFN-g 
compared with untreated controls when stimulated with the 
immunizing alloantigen but not the irrelevant alloantigen. Thus, 
antigen-specific Tregs induced by immunization and UV irradi-
ation were characterized as CD4+ T regulatory type 1 (Tr1) cells.
Serum levels of IL-10
Serum levels of collected blood samples were under the detec-
tion limit at all time points after UV irradiation (data not shown).
Stimulation of responder T cells by anti-CD3 mAb in MLC
We stimulated cytokine production of CD4+T cells in MLC by 
anti-CD3 mAb. Mice were divided into 4 groups: (i) untreat-
ed control, (ii) immunized control, (iii) UV-irradiated control, 
and (iv) immunized/UV-irradiated group. MLCs with anti-CD3 
mAb were repeated 4 times, and supernatants were harvest-
ed for ELISA (Figure 8).
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Figure 8.  IL-10 production in MLC stimulated 
with anti-CD3 mAb. (A) Proliferation 
of responder CD4+T cells. (B) IL-10 
concentration. *, p<0.05.
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There was no significant difference in 3H-TdR incorporation 
between all groups and untreated controls when stimulat-
ed with the immunizing or irrelevant alloantigen (Figure 8A).
Stimulation with the immunizing alloantigen showed signifi-
cant differences in IL-10 production in the UV-irradiated control 
(p=0.0389) and immunized/UV-irradiated groups (p=0.0096) but 
not the immunized controls (p=0.8590) when compared with 
the untreated controls. Stimulation with the irrelevant stimula-
tor showed significant differences in IL-10 production in the UV-
irradiated control (p=0.0004) and immunized and UV-irradiated 
groups (p=0.0036) but not the immunized controls (p=0.3864) 
when compared with the untreated controls (Figure 8B).
IL-10 production from CD4+T cells in immunized and UV-
irradiated mice was clearly enhanced by anti-CD3 mAb 
stimulation.
Transferable CD4+ Tr1 induced by immunization and UV 
irradiation mediated antigen-specific prolongation of 
allograft survival
Based on the above results, we investigated whether allo-
antigen-specific immunosuppression depended on CD4+ Tr1 
cells induced by immunization and UV irradiation. CD4+T cells 
were purified from pooled splenocytes of immunized and UV-
irradiated mice at 4 weeks after UV irradiation (Figure 1). Totals 
of 5×105, 1×106, 5×106, 1×107, and 5×107 splenic CD4+T cells 
were transferred into naïve B6 mice. Thereafter, allografts ex-
pressing either the immunizing or irrelevant alloantigen were 
immediately engrafted to the transferred mice. Five transferred 
mice received each dose. Survival curves are shown in Figure 9.
In skin transplantations, survival of allografts presenting the 
immunizing alloantigen in CD4+T transferred mice were mark-
edly prolonged dose-dependently (p=0.1762, 0.0494, 0.0016, 
0.0016, and 0.0016, for CD4+T transfer of 5×105, 1×106, 5×106, 
1×107, and 5×107 cells/mouse, respectively) compared with 
PBS transferred mice (Figure 9A). In contrast, survival of al-
lografts presenting the irrelevant alloantigen showed no pro-
longation when compared with PBS transferred mice, even in 
mice administered high-dose cell transfer (p=0.5485, 0.2055, 
0.0528, 0.0528, and 0.0993, at CD4+T transfers of 5×105, 1×106, 
5×106, 1×107, and 5×107 cells/mouse, respectively) (Figure 9B).
CD4+T cells transferred mice from immunized/UV-irradiated 
mice clearly showed the dose-dependent alloantigen-specif-
ic prolongation of skin allograft survival, although the immu-
nosuppressive effects plateaued at a dose of >5×106 CD4+T 
cells/mouse.
Next, cardiac grafts were engrafted to mice receiving 5×106 
CD4+T cells. In heart transplantation, survival of allografts pre-
senting the immunizing alloantigen in CD4+T transferred mice 
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Figure 9.  Allograft survivals in CD4+T transferred mice. (A) Survival of skin allografts presenting the immunizing alloantigen. 
(B) Survival of skin allografts presenting an irrelevant alloantigen. (C) Survival of cardiac allografts presenting the immunizing 
alloantigen. (D) Survival of cardiac allografts presenting an irrelevant alloantigen.
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were clearly prolonged (p=0.0017) compared with PBS trans-
ferred mice (Figure 9C). In contrast, survival of allografts pre-
senting the irrelevant alloantigen showed no prolongation in 
CD4+T transferred mice when compared with PBS-transferred 
mice (p=0.2242) (Figure 9D).
Alloantigen-specific immunosuppression induced by immuni-
zation and UV irradiation depended on CD4+ Tr1 cells.
Abrogation of alloantigen-specific immunosuppression by 
IL-10 blocking
Finally, to clarify a role of IL-10 in the induction of Tregs by 
immunization and UV irradiation, immunized/UV-irradiated 
mice were treated with anti-IL-10 mAb intravenously before 
(day –1) and after (day +1) UV-B irradiation. Mice were divid-
ed into 3 groups: (i) untreated control, (ii) immunized/UV ir-
radiated control, and (iii) immunized/UV-irradiated mice with 
anti-IL-10 mAb treatment. MLRs and MLCs were repeated 4 
times. Five mice per group received allograft transplantation, 
and no rejections were observed in syngeneic grafts (Figure 10).
In proliferation assay by MLRs with stimulator cells presenting 
the immunizing alloantigen, there was a significant difference 
in 3H-TdR incorporation in the immunized/UV-irradiated con-
trols (p=0.0006) but not the anti-IL-10 mAb treated group 
(p=0.2671) (Figure 10A).
In MLCs using responder CD4+T cells and stimulator cells pre-
senting the immunizing alloantigen, there was a significant 
difference in IL-10 production in the immunized/UV-irradiated 
controls (p=0.0027) but not the anti-IL-10 mAb treated group 
(p=0.3559) (Figure 10B) when compared with the untreat-
ed controls. In transplantation with skin allografts presenting 
the immunizing alloantigen, there were significant differenc-
es in allograft survival of the immunized/UV-irradiated control 
(p=0.0016) but not the anti-IL-10 mAb treated group (p=0.1762) 
when compared with the untreated controls (Figure 10C).
In transplantation with cardiac allografts presenting the im-
munizing alloantigen for immunization, there were signifi-
cant differences in allograft survival of the immunized/UV-
irradiated control (p=0.0018) but not the anti-IL-10 mAb 
treated group (p=0.1168) when compared with the untreat-
ed controls (Figure 10D).
Treatment with anti-IL-10 mAb markedly abrogated the allo-
antigen-specific immunosuppression induced by immunization 
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Figure 10.  Abrogation of alloantigen-specific immunosuppression by blocking IL-10. (A) Proliferation assays. (B) IL-10 concentration 
in MLC supernatants. (C) Survival of skin allografts presenting the immunizing alloantigen. (D) Survival of cardiac allografts 
presenting the immunizing alloantigen. *, p<0.05.
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and UV irradiation. These results suggests that IL-10 plays an 
important role in the induction of alloantigen-specific CD4+ Tr1 
cells in immunized and UV-irradiated mice.
Discussion
UV light is one of the most important environmental factors 
affecting human health [1–4]. UV-B exposure induces skin tu-
mors by a direct effect on DNA gene mutations and an indirect 
effect on immune responses [1,3,4]. UV-B exposure can sup-
press immune responses to various antigens [1,3,4]. In 1974, 
the first observation of the immunosuppressive effects of UV-B 
irradiation was reported [37]. UV-B irradiation results in the in-
duction of highly antigenic skin cancers [2,37]. Moreover, im-
munosuppressive activity of UV-B-induced Tregs is highly selec-
tive, and the development of primary UV-B-induced tumors, but 
not other syngeneic tumors, is suppressed [2,37]. Furthermore, 
UV-B-induced immunosuppression could be transferred to nor-
mal syngeneic hosts by Tregs [38,39] and antigen-specific Tregs 
were also transferable [11,29,38,39]. Paradoxically, the capaci-
ty to modify immune responses by UV irradiation began to be 
used therapeutically in the 1970s [1,3].
Two models using UV-B irradiation have been developed 
[1,10,11,27]. Acute low-dose UV-B irradiation induces an inhi-
bition of the local sensitization phase of contact hypersensi-
tivity (CHS) responses to a hapten applied to UV-B irradiated 
skin [1,2,40]. High-dose UV-B irradiation induces inhibition of 
the systemic sensitization phase of CHS responses to a hap-
ten and DTH to alloantigens applied to distant non-irradiat-
ed skin [1,2,7–11,26–28,33,41]. Both models are associat-
ed with the production of transferable antigen-specific Tregs 
[1,7,10,11,26,28,33]. It was suggested that the mechanisms 
and pathways involved in the immunosuppression of CHS and 
DTH induced by UV-B irradiation differ [27]. Our data clear-
ly demonstrated that UV-B irradiation after alloantigen im-
munization is useful for immunosuppression in a DTH model.
High-dose UV-B irradiation induces the alternation or modu-
lation of antigen-presenting cell (APC) functions for the induc-
tion of antigen-specific Tregs [1,3,5,7,10,26,29–31,42]. The ear-
ly phase of APC functions after high-dose UV-B irradiation has 
been well studied [3,6,29,43,44]. UV-induced DNA damage has 
been recognized as the major molecular trigger for photoim-
munosuppression [3,4,45]. UV exposure alters the morphology 
and function of epidermal Langerhans cells (LCs), which play a 
role in UV-B-induced immunosuppression [46]. LCs were regard-
ed as the most important APC in the epidermis [47–49], and it 
was formerly believed that LCs were killed by UV irradiation. 
It is also believed that UV-B exposure triggers the migration 
of immature LCs from the skin to the draining lymph nodes, 
where they induce tolerance [46]. UV-B-induced migration of 
mast cells to draining lymph nodes is also considered an im-
portant early step in UV-B-induced immunosuppression [43,50]. 
Currently, the functional role of LCs has been redefined, and 
UV-damaged LCs in the regional lymph nodes were required 
for the Treg induction [45]. Damaged but still-alive LCs will 
present antigen in a unusual manner, and then, this presen-
tation will induce not effect T cells, but will affect Tregs [4]. 
UV-B irradiation alters the ability of APCs to activate helper 
T cells and UV-resistant APCs to induce Tregs [10,26,32]. This 
might explain the antigen specificity of UV-B-induced immu-
nosuppression, and also why antigen immunization must fol-
low UV-B irradiation and not vice versa [7,10,26].
CD4+ and CD8+ T cells play critical roles during allograft re-
jection in transplantation [15,33,51–53]. UV-induced antigen-
specific immunosuppression is attributable to T cells with 
suppressive activity (formerly so-called ‘suppressor T cells’) 
[54,55], and currently these T cells are renamed as Treg [56–
58]. A number of studies have investigated the phenotype and 
mechanism of UV-B-induced Tregs. UV-induced Tregs express 
CD4, CD25, and CTLA4 [56,59,60]. Most UV-induced Tregs be-
long to the CD4+ phenotype [58], and immunosuppressive ef-
fects induced by UV irradiation are mediated by CD4+T cells 
[28,61,62]. These Tregs also express the lymph node-homing 
receptor (CD62L) and migrate into the lymph nodes [60,63]. 
Therefore, UV-induced Tregs primarily inhibit sensitization. To 
detect the phenotype of Tregs induced by UV irradiation after 
immunization, we had reported that CD4+T cells did not express 
CD25, CTLA4, or Foxp3 [22–25] and that T cells sorted by only 
CD4 involved Treg populations with IL-10. Immunosuppressive 
effects induced by UV-B irradiation were mediated by CD4+T 
cells [7,11,26,28,33,61], and CD4+T cells induced by UV irra-
diation after immunization worked well in our DTH model.
CD3+, CD4+, and CD8+ Tregs mediated immunosuppressive ef-
fects by releasing IL-4 and IL-10 [11,33,64]. UV-B-induced im-
munosuppression might also be explained by a shift in the 
activation of T cells from a Th1 to a Th2 immune response 
[26,28,65,66]. CD4+ Th2 lymphocytes secrete pro-inflamma-
tory cytokines (IL-4, IL-5, and IL-13) [67,68]. IL-4 is thought to 
promote the induction of transplantation tolerance and allo-
antigen-specific Tregs [17]. IL-4 also promotes both regula-
tory and effector T cells early in the immune response, but 
once alloimmune tolerance is established, IL-4 promotes the 
activation of effector cells to mediate rejection and does not 
support alloantigen-specific Tregs that could transfer specif-
ic tolerance [17]. Although IL-10 is a well-known immunosup-
pressive cytokine [33,69] TGF-b is a growth and differentiation 
factor that displays multiple functions [70]. It was suggest-
ed that the combined use of IL-10 with other inhibitory cyto-
kines such as TGF-b might be have more effect on CD4+ Tregs 
[33,70,71]. Our results support that immunosuppression in-
duced by UV irradiation after immunization is dependent on 
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CD4+ Tregs. However, our results regarding cytokine profiles 
suggest that alloantigen-specific immunosuppression induced 
by UV irradiation after immunization does not depend on IL-4, 
IL-5, IL-13, or TGF-b. As in previous reports, Tregs induced by 
UV irradiation before immunization showed the differences in 
IL-4, IL-5, and TGF-b [26,28,52,53], and our preliminary data 
may also explain immunosuppressive effects induced by UV ir-
radiation before immunization by a Th2 shift (data not shown). 
Our data support the idea that UV-B-induced immunosuppres-
sion is dependent on CD4+ Tregs, although the mechanism of 
immunosuppression induced by UV irradiation after immuni-
zation is not a Th2 shift.
Cytokines are important for UV-B-induced immunosuppression 
[11,12,27,42,53,64]. Especially, a role of IL-10 in high-dose UV-B 
irradiation was demonstrated [11,12,27,33,53,72]. High-dose 
UV-B is almost entirely absorbed within the epidermis [27], and 
UV-B irradiation causes damage to keratinocytes [27], which pro-
duce both IL-10 mRNA and protein in vitro [73], and thus are a 
likely source of IL-10 [27]. Apoptosis may also play an impor-
tant role in UV-B-induced immunosuppression [1,74]. It is un-
likely that UV-B-induced damage has a direct effect on T cells, 
because UV-B has a low penetration of skin [1]. It is considered 
that FasL expression on DNA-damaged LCs may stimulate Treg 
production, which may induce apoptosis in effector T cells [1]. 
FasL expression on DNA-damaged LCs may directly induce apop-
tosis of antigen-specific effector T cells [75]. Secretion of IL-4 
and IL-10 from UV-B-induced apoptotic cells mediates immuno-
suppressive effects [1,76] and lymphocyte apoptosis is linked 
to IL-10 secretion [76]. In our model, possible sources of IL-10 
may be apoptotic lymph nodes and/or damaged keratinocytes.
IL-10 is considered necessary for UV-B-induced immunosup-
pression [12,27,33,77–79]. Transferred IL-10-producing T cells 
inhibited the priming of alloantigen-specific CD4+T cells, and 
subsequent induction of alloantigen-specific CD8+T cells [33]. 
Transferred IL-10 CD4+T cells migrated to the site of allografts 
and directly inhibited the function of alloantigen-specific cy-
totoxic CD8+T cells [33]. The inhibitory capacity of UV-induced 
Tregs crucially depends on IL-10 [60]. Antigen-specific activation 
of Treg by APC induces the release of IL-10 [59,60] and inhib-
itory activity of UV-induced Treg is mediated by IL-10 [59,80]. 
From the viewpoint of the source of IL-10, UV-induced Treg 
itself [56,77], mast cells [81], and CD11b+ macrophages [82] 
were listed. Thus, IL-10 is crucial for both the induction and 
effector phases [11,33,73,76,78], but some researchers sug-
gested that IL-10 is not required for Treg induction by UV irra-
diation [79]. IL-10 blocking data in the current study supports 
the importance of IL-10 for CD4+ Treg induction by immuniza-
tion and UV-B irradiation.
Surprisingly, only CD4+T cells from immunized/UV-irradiated 
mice produced IL-10 when stimulated with the immunizing 
alloantigen but not an irrelevant alloantigen. In this study, we 
used B6 mice as recipients, because B6 mice are Th1 prone 
[52]. This might explain why serum IL-10 was not detected. 
However, CD4+T cells from immunized and UV-irradiated B6 
mice produced a large amount of IL-10 in an alloantigen-spe-
cific manner. High levels of IL-10 and low levels of IL-4 resem-
ble a Tr1 cytokine pattern [83]. The presence of IL-10 gives rise 
to CD4+T-cell clones with a low proliferative capacity that in 
turn produce high levels of IL-10, low levels of IL-2, and no IL-4 
[69,83]. These antigen-specific T cell clones suppress the pro-
liferation of CD4+T cells in response to antigen [69,83]. Thus, 
IL-10 drives the generation of a CD4+T-cell subset, designat-
ed Tr1, which suppresses antigen-specific immune responses 
and actively down-regulates pathological immune responses 
in vivo [69,83]. Paradoxically, it may explain why T cells sort-
ed by only CD4 well worked in our model. In our model, CD4+ 
Treg and a high level of IL-10 are important for alloantigen-
specific immunosuppression.
Untreated control and immunized control showed similar sur-
vivals of allografts presenting the same alloantigen. Some ques-
tions arose. Although UV-irradiated control and immunized/
UV-irradiated group showed the differences, does alloantigen 
immunization work well? Does stronger immunization provide 
more enhanced results? DC are specialized APCs that moni-
tor the antigenic environment and activate naïve T cells [84]. 
The role of DC is to sense danger and tolerize the immune sys-
tem to antigens encountered [84]. If naïve T cells encounter 
antigens on DC under certain conditions, they can differenti-
ate into Tregs rather than effector T cells [84]. The induction 
of Tregs by DC in the presence of IL-10 has been documented 
[53,69,85,86], and bone marrow-derived DC can induce Tr1 dif-
ferentiation [87,88]. Therefore, we initially expected that allo-
antigen immunization by bone marrow-derived DC would en-
hance alloantigen-specific immunosuppression. IL-10 is key 
for inducing and mediating tolerance [84], and UV-B-induced 
Tregs released a large amount of IL-10. We failed to enhance 
the immunosuppressive effect by using bone marrow-derived 
mature DC in our model, which might suggest the difficulty of 
memorization of alloantigen to UV-B-induced Tr1. A possible 
explanation for similar survivals between untreated and im-
munized controls was that transplanted allografts in this study 
had strong antigenicity.
Under the stimulation in MLC with anti-CD3 mAb, proliferation 
of responder CD4+T cells and IL-10 concentration in the super-
natants were increased in all UV-irradiated groups. An inter-
esting finding of this study is that high-dose UV-B irradiation 
alone seemed to result in pan-immunosuppression, although 
it was documented that UV-B-induced Tregs are highly selec-
tive for UV-B-induced cancer [2,37]. Moreover, we showed that 
the UV-B-induced pan-immunosuppressive effect was related 
to the time course. An explanation for this is that we used a 
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higher dose of UV-B (40 kJ/m2) than previous studies. In ad-
dition, the antigenicity of cardiac allografts might be weaker 
than for skin allografts, and thus some cardiac allografts sur-
vived even at 4 weeks after UV-B irradiation alone.
Interestingly, our results revealed that CD4+ Tregs induced by 
UV irradiation after immunization seemed to produce a subtle 
IL-10 in the stimulation with the irrelevant alloantigen. A pos-
sible explanation for this phenomenon was that UV-induced 
Tregs will show an unique behavior, so-called ‘bystander sup-
pression’ [60,77,89]. The antigen specificity appears to be re-
stricted to the activation of UV-induced Tregs and not to the 
suppressive activity itself, because once activated antigen-spe-
cifically, they release IL-10 and thereby suppress also other im-
mune reactions. Further studies were required to explain this 
phenomenon, and we now are performing advanced studies 
in this DTH model by using the third-party alloantigen (H-2d/k).
Furthermore, high-dose UV-B irradiation after alloantigen im-
munization, but not before immunization, is a useful tool for 
transferable Treg induction. We clearly demonstrated ben-
eficial immunosuppression via alloantigen-specific Tr1-like 
CD4+T cells. UV-B irradiation to the recipient several days be-
fore transplantation is impractical, because predicting when 
a donor organ will be available is difficult. Alloantigen immu-
nization before UV-B irradiation, suggested by the data here, 
may be clinically advantageous. The view of UV-induced im-
munology has changed over the past several years [3,4]. 
Carcinogenesis and immunosuppression due to UV were re-
garded as detrimental, but now it is thought that a fine-tuned 
balance is optimal [3,4]. In order to induce alloantigen-specific 
and transferable CD4+ Tr1 cells, UV is a very useful tool in the 
DTH model. Alloantigen-specific immunosuppression is ideal 
for transplant recipients.
Clinically, there is great enthusiasm about the potential to 
develop strategies that can use Tregs for therapeutic inter-
vention [77].
Conclusions
Induction of alloantigen-specific Tregs by alloantigen immu-
nization and UV-B irradiation may have therapeutic potential. 
Although we are far from a full understanding of the mechanism 
involved, beneficial effects of alloantigen immunization and UV-B 
irradiation via alloantigen-specific Tr1-like CD4+T cells were clearly 
observed. This transferable Treg may be useful, especially in the 
field of transplant immunology. We hope that our new insights 
will help many researchers in the transplant immunology field.
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